Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Postgraduate Medicine
|
May 14, 2010
Zoledronic acid reduces osteoporotic fractures and ensures medication compliance for 1 year
Jeffrey P Levine
Journal of Women'S Health (2002)
|
March 7, 2008
Type 2 diabetes among women: clinical considerations for pharmacological management to achieve glycemic control and reduce cardiovascular risk
Jeffrey P Levine
Clinical Cornerstone
|
June 27, 2007
Pharmacologic and nonpharmacologic management of osteoporosis
Jeffrey P Levine
The Journal of Family Practice
|
November 6, 2004
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences
Jeffrey P Levine
Gender Medicine
|
May 4, 2011
Treating menopausal symptoms with a tissue-selective estrogen complex
Jeffrey P Levine
Current Women'S Health Reports
|
May 8, 2003
Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis
Jeffrey P Levine
The American Journal of Managed Care
|
July 19, 2011
Identification, diagnosis, and prevention of osteoporosis
Jeffrey P Levine
Geriatrics
|
November 15, 2007
Effective strategies to identify postmenopausal women at risk for osteoporosis
Jeffrey P Levine
Family Medicine
|
February 2, 2006
Neo-Pagan patients' preferences regarding physician discussion of spirituality
Jennifer L Hamilton, Jeffrey P Levine
Menopause (New York, N.Y.)
|
July 28, 2010
Preventing osteoporosis in symptomatic postmenopausal women
J Christopher Gallagher, Jeffrey P Levine
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Postgraduate Medicine
|
May 14, 2010
Zoledronic acid reduces osteoporotic fractures and ensures medication compliance for 1 year
Jeffrey P Levine
Journal of Women'S Health (2002)
|
March 7, 2008
Type 2 diabetes among women: clinical considerations for pharmacological management to achieve glycemic control and reduce cardiovascular risk
Jeffrey P Levine
Clinical Cornerstone
|
June 27, 2007
Pharmacologic and nonpharmacologic management of osteoporosis
Jeffrey P Levine
The Journal of Family Practice
|
November 6, 2004
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences
Jeffrey P Levine
Gender Medicine
|
May 4, 2011
Treating menopausal symptoms with a tissue-selective estrogen complex
Jeffrey P Levine
Current Women'S Health Reports
|
May 8, 2003
Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis
Jeffrey P Levine
The American Journal of Managed Care
|
July 19, 2011
Identification, diagnosis, and prevention of osteoporosis
Jeffrey P Levine
Geriatrics
|
November 15, 2007
Effective strategies to identify postmenopausal women at risk for osteoporosis
Jeffrey P Levine
Family Medicine
|
February 2, 2006
Neo-Pagan patients' preferences regarding physician discussion of spirituality
Jennifer L Hamilton, Jeffrey P Levine
Menopause (New York, N.Y.)
|
July 28, 2010
Preventing osteoporosis in symptomatic postmenopausal women
J Christopher Gallagher, Jeffrey P Levine
Page
of 2